288 related articles for article (PubMed ID: 25637802)
1. Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.
Wong MY; Borgkvist A; Choi SJ; Mosharov EV; Bamford NS; Sulzer D
Neuroscience; 2015 Apr; 290():594-607. PubMed ID: 25637802
[TBL] [Abstract][Full Text] [Related]
2. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
Pinna A; Bonaventura J; Farré D; Sánchez M; Simola N; Mallol J; Lluís C; Costa G; Baqi Y; Müller CE; Cortés A; McCormick P; Canela EI; Martínez-Pinilla E; Lanciego JL; Casadó V; Armentero MT; Franco R
Exp Neurol; 2014 Mar; 253():180-91. PubMed ID: 24412491
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism.
Bonito-Oliva A; Pignatelli M; Spigolon G; Yoshitake T; Seiler S; Longo F; Piccinin S; Kehr J; Mercuri NB; Nisticò R; Fisone G
Biol Psychiatry; 2014 May; 75(9):701-10. PubMed ID: 23541633
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
6. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
8. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
[TBL] [Abstract][Full Text] [Related]
9. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
[TBL] [Abstract][Full Text] [Related]
10. Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease.
Bentea E; Moore C; Deneyer L; Verbruggen L; Churchill MJ; Hood RL; Meshul CK; Massie A
Brain Res Bull; 2017 Apr; 130():257-267. PubMed ID: 28232022
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
[TBL] [Abstract][Full Text] [Related]
12. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
[TBL] [Abstract][Full Text] [Related]
13. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
[TBL] [Abstract][Full Text] [Related]
14. Dopamine modulates release from corticostriatal terminals.
Bamford NS; Robinson S; Palmiter RD; Joyce JA; Moore C; Meshul CK
J Neurosci; 2004 Oct; 24(43):9541-52. PubMed ID: 15509741
[TBL] [Abstract][Full Text] [Related]
15. Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats.
Billet F; Costentin J; Dourmap N
Exp Neurol; 2012 Aug; 236(2):339-50. PubMed ID: 22575599
[TBL] [Abstract][Full Text] [Related]
16. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice.
Madeo G; Schirinzi T; Maltese M; Martella G; Rapino C; Fezza F; Mastrangelo N; Bonsi P; Maccarrone M; Pisani A
Neuropharmacology; 2016 Feb; 101():460-70. PubMed ID: 26498506
[TBL] [Abstract][Full Text] [Related]
18. Reinforcing properties of Pramipexole in normal and parkinsonian rats.
Engeln M; Ahmed SH; Vouillac C; Tison F; Bezard E; Fernagut PO
Neurobiol Dis; 2013 Jan; 49():79-86. PubMed ID: 22940424
[TBL] [Abstract][Full Text] [Related]
19. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
